Carbon Logic Biotech
License-out partnership of colorectal cancer molecular diagnostics
Carbon Logic Biotech develops molecular diagnostics, prognostic and predictive tests for colorectal cancer patients. Our molecular diagnostics address unmet medical needs of colorectal cancer patients. These tests are validated using our proprietary RNAseq datasets of formalin-fixed, paraffin-embedded (FFPE) samples. We seek a partner to license out our 3 molecular diagnostics products.
Looking for licensing partnership
December 30, 2024
Nov. 12th, 2022
The BioPacific Conference is the annual flagship event of the CABS. Our mission is to bring scientists, executives, and bio-pharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the world of life sciences, the unprecedented challenges and promises facing the industry, and the breath-taking developments and opportunities in Asia/Pacific countries